Bill Young is an accomplished business leader with extensive experience within life sciences and pharmaceuticals. He spent nearly two decades at Genentech, Inc serving as its COO from 1997 to 1999, and as Chairman and CEO of Monogram Biosciences, Inc from 1999 to 2009.
Previously he served as the Chairman of the Board of Directors at Biogen Idec and as a member of the board of directors at Biomarin Pharmaceutical. Since 2010, Bill has been a senior advisor at Blackstone Life Sciences and has directorships on the boards of Annexon, SFJ Pharmaceuticals, Praxis Precision Medicine, and Vertex Pharmaceuticals.
In 1993, Bill was elected to the National Academy of Engineering for his contributions to biotechnology. He holds a Bachelor of Science degree in Chemical Engineering from Purdue University, an MBA from Indiana University, and an Honorary Doctorate in Engineering from Purdue University.